QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$41.05 USD
-0.92 (-2.19%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $41.04 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.05 USD
-0.92 (-2.19%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $41.04 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Zacks News
Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $159.39, moving -1.12% from the previous trading session.
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Quidel, QIAGEN and Thermo Fisher Scientific
Quidel Enters Oversold Territory
by Zacks Equity Research
Quidel has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Coronavirus Test Makers With Scope to Maximize Investor Benefits
by Urmimala Biswas
The surge in new coronavirus infections broadens the scope for antigen and antibody tests.
Omeros (OMER) Catches Eye: Stock Jumps 6%
by Zacks Equity Research
Omeros (OMER) saw a big move last session, as its shares jumped 6% on the day, amid huge volumes.
Top Stock Picks for Week of September 8, 2020
by Panel Of Zacks Experts
Take a look at our expert's weekly picks which include Quidel (QDEL) and American Woodwork (AMWD).
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Surface Oncology (SURF) Looks Good: Stock Adds 9.8% in Session
by Zacks Equity Research
Surface Oncology (SURF) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics
Price War in Coronavirus Test Space to Intensify Thanks to Abbott
by Urmimala Biswas
Most rapid antigen tests in the United States require an additional system, which is making the procedures more costly and complex.
7 Top-Ranked Corporate Giants With More Than 50% Return YTD
by Nalak Das
A handful of corporate giants (market capital > $10 billion) have skyrocketed this year, braving the pandemic and its impact on businesses.
Has Quidel (QDEL) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Should iShares Morningstar SmallCap Growth ETF (JKK) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKK
Bull of the Day: Quidel (QDEL)
by Kevin Cook
Multiple FDA approvals for new 15-minute COVID-19 antigen tests have estimates and shares rising sharply
Quidel's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Quidel.
ICU Medical (ICUI) Looks Good: Stock Adds 8.1% in Session
by Zacks Equity Research
ICU Medical (ICUI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novava, Veritone, Kopin, Quidel and Unum Therapeutics
Encompass Health's (EHC) Expansion Plans Continue in Florida
by Zacks Equity Research
Encompass Health (EHC) continues to expand in Florida via hospitals in order to offer improved health services in the state.
Grab These Stocks With Momentum Anomaly for Better Returns
by Zacks Equity Research
These fast movers are currently witnessing a short-term pullback in price. So make sure you're making the most of this opportunity.
Nasdaq Tops 11,000: 5 Best Stocks With Room for More Upside
by Sweta Killa
On Aug 6, the Nasdaq Composite Index topped the milestone of 11,000. The tech-heavy laden completed its 1000-point journey in 40 trading days, representing the fastest ever rise in 20 years.
The Zacks Analyst Blog Highlights: Nautilus, Veritone, Quidel, DocuSign and Shopify
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nautilus, Veritone, Quidel, DocuSign and Shopify
5 Growth ETFs & Stocks to Ride the Market Rally
by Sweta Killa
Growth investing has taken the lead over value and is likely to stay given a slew of reasons.
The Zacks Analyst Blog Highlights: PulteGroup, Quidel, D.R. Horton and West Pharmaceutical Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PulteGroup, Quidel, D.R. Horton and West Pharmaceutical Services
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Wall Street is Northbound Defying All Concerns: 5 Top Picks
by Nalak Das
A new bull market that was developed last quarter exiting the coronavirus-induced short bear market, is raging forward in the third quarter too.